Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06144112
Other study ID # HC22195220002003
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date March 1, 2024
Est. completion date April 1, 2025

Study information

Verified date November 2023
Source Konkuk University Medical Center
Contact Tae-Yop Kim, MD PhD
Phone +82-10-8811-6942
Email taeyop@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for liver transplantation surgery.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 92
Est. completion date April 1, 2025
Est. primary completion date April 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria: - Liver disease undergoing Liver transplantation Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
fresh frozen plasma
transfusion of fresh frozen plasma
prothrombin complex concentrate
prothrombin complex concentrate administration

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Konkuk University Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary duration from the time diagnosing r-time prolongation to the time achieving bleeding control 1 min
Secondary Red Blood Cell amount Red Blood Cell transfusion amount during surgery 1 hour
Secondary FFP amount FFP transfusion amount during surgery 1 hour
Secondary Platelet amount Platelet transfusion amount during surgery 1 hour
Secondary r-time CK r-time after PCC or FFP 10 min
Secondary CRT-MA CRT-MA after PCC or FFP 10 min
Secondary CFF-MA CFF-MA after PCC or FFP 10 min
Secondary Bleeding Postoperative bleeding amount 6 hour
Secondary oxygenation profile PaO2/FiO2 ratio 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT05255042 - Tissue Models for Liver Disease
Completed NCT04473482 - Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial N/A
Not yet recruiting NCT05120557 - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH N/A
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Recruiting NCT03773887 - Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease N/A
Recruiting NCT00345930 - DILIN - Prospective Study
Completed NCT00148031 - Improving Hepatitis C Treatment in Injection Drug Users Phase 4
Terminated NCT00031135 - Total Parenteral Nutrition-Associated Liver Disease Phase 2
Completed NCT00005305 - Hepatitis Delta Infections in Hemophiliacs N/A
Completed NCT00005304 - Delta Hepatitis and Liver Disease in Hemophiliacs
Completed NCT00222664 - Qidong Hepatitis B Intervention Study Phase 4
Recruiting NCT06195917 - Robotic-assisted Percutaneous Transhepatic Puncture N/A
Recruiting NCT04551742 - Social & Contextual Impact on Children Undergoing Liver Transplantation
Completed NCT04782050 - Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation N/A
Completed NCT03614039 - Effect of Probiotic and Smectite Gel on NAFLD N/A
Recruiting NCT04518852 - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC Phase 2
Recruiting NCT05499585 - Treating Pediatric NAFLD With Nutrition N/A
Terminated NCT03396705 - Liver Regeneration
Completed NCT04341012 - Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
Recruiting NCT05733832 - A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease N/A